MDSpire - Summary
Clinical Guidelines
Feature

Integrative Oncology Scholars Program

Applications are now being accepted for the 2026 Integrative Oncology Scholars Program and Integrative Oncology Fellows Program at the University of Michigan in Ann Arbor (https://sites.google.com/vie...

Share

The University of Michigan is accepting applications for the 2026 Integrative Oncology Scholars Program and Fellows Program. This educational initiative provides training to assess the scientific validity of complementary therapies such as acupuncture and nutrition for alleviating cancer treatment side effects. The program, now in its sixth year, has trained over 120 healthcare professionals across various fields, offering a 1-year certificate and a 2-year fellowship with eligibility for board certification from the American Board of Integrative Medicine. Applications are due by May 30, 2026.

Original Source(s)

Integrative Oncology Scholars Program

  • by Jo Cavallo

  • March 24, 2026

Related Content

Stanford Names Leader for Drug Development and Precision Oncology

Vivek Subbiah, MD, has been appointed as the inaugural associate director for drug development and precision oncology at the Stanford Cancer Institute, with a planned start date in spring 2026. In thi...

In Celebration of a Decades-Long Journey of Discovery and Innovation

On October 1, 2025, Benjamin L. Ebert, MD, PhD, celebrated the 1-year anniversary of being named President and Chief Executive Officer (CEO) of Dana-Farber Cancer Institute in Boston. He also holds th...

FDA Approves Teclistamab and Daratumumab For Relapsed or Refractory Multiple Myeloma

On March 5, 2026, the U.S. Food and Drug Administration (FDA) approved teclistamab (Tecvayli) in combination with daratumumab hyaluronidase-fihj for the treatment of adult patients with relapsed or re...